American Society Of Cytopathology is located in Wilmington, DE. The organization was established in 1975. As of 06/2022, American Society Of Cytopathology employed 5 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. American Society Of Cytopathology is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, American Society Of Cytopathology generated $1.3m in total revenue. The organization has seen a slow decline revenue. Over the past 6 years, revenues have fallen by an average of (1.3%) each year. All expenses for the organization totaled $1.3m during the year ending 06/2022. As we would expect to see with falling revenues, expenses have declined by (0.5%) per year over the past 6 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
SEE ATTACHED
Describe the Organization's Program Activity:
EDUCATION & INFORMATION; THE SOCIETY DISTRIBUTES AND PUBLISHES MEDICAL PERIODICALS, JOURNAL OF AMERICAN SOCIETY OF CYTOPATHOLOGY AND THE ASC BULLETIN; MAILED TO OVER 3,000 MEMBERS.
THE 69TH ANNUAL SCIENTIFIC MEETING IS A 4 DAY EVENT THAT OVER 650 PROFESSIONALS ATTENDED. THE MEETING CONSISTS OF SCIENTIFIC LECTURES, CYTOLOGY WORKSHOPS, SPECIAL COURSES, DIAGNOSTIC SEMINARS, POSTER AND PLATFORM SESSIONS, PANEL LUNCHEON SEMINARS, VIDEO MICROSCOPE TUTORIALS, ROUNDTABLE DISCUSSIONS AND TECHNICAL EXHIBITS.THE MEETING IS AVAILABLE TO AND ATTENDED BY PATHOLOGISTS, CYTOPATHOLOGISTS, CYTOTECHNOLOGISTS, RESIDENTS FELLOWS, STUDENTS, AND OTHER MEMBERS OF RELATED MEDICAL AND SCIENTIFIC FIELDS.
THE ASC'S CONTINUING EDUCATION EFFORTS STARTED AT THE INITIAL ANNUAL MEETING IN 1953 AND HAS CONTIUED FOR 69 YEARS. THE EDUCATIONAL PROGRAMS OF THE ASC ARE OF PRIME IMPORTANCE TO IT'S MEMBERS AND THE TO THE EXPERIMENTAL/NEWLY AVAILABLE TECHNIQUES INTO RESERACH AND CLINICAL PRACTICE, AND ADDRESSES THIS NEED THROUGH ITS EDUCATIONAL PROGRAMS. TO MEET THE EDUCATIONAL NEEDS OF ITS CONSTITUENTS , THE ASC HAS DEVELOPED AN AMBITIOUS SET OF INTERGRATED ACTIVITIES; ANNUAL MEETING, CYTO-ECONFERENCE, ADVANCED CYTOPATHOLOGY EDUCATION COURSE, CASE STUDIES, EJOURNAL, PROGRESSIVE EVALUATION OF COMPETENCY, CELL TALKS AND CELL WEB SITE.
CPRC CYTOTECHNOLOGY PROGRAMS REVIEW COMMITTEE - CONDUCTS ON-SITE SURVEYS OF CYTOTECHNOLOGY SCHOOLS AND MAKES RECOMMENDATIONS FOR ACCREDITATION TO CAAHEP.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Elizabeth Jenkins Executive Director | OfficerTrustee | 40 | $126,166 |
Martha B Pitman President | Officer | 5 | $0 |
Liron Pantanowitz MD President Elect | Officer | 5 | $0 |
Sara Monaco MD Executive Board Member | Officer | 5 | $0 |
Momin T Siddiqui MD Vice-President | Officer | 5 | $0 |
Amy C Clayton MD Secretary-Treasurer | Officer | 5 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $68,506 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $0 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $68,506 |
Total Program Service Revenue | $1,039,638 |
Investment income | $212,414 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $1,320,558 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $20,770 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $145,091 |
Compensation of current officers, directors, key employees. | $145,091 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $253,877 |
Pension plan accruals and contributions | $30,825 |
Other employee benefits | $57,411 |
Payroll taxes | $27,706 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $37,182 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $6,396 |
Fees for services: Other | $0 |
Advertising and promotion | $20,397 |
Office expenses | $4,102 |
Information technology | $42,180 |
Royalties | $0 |
Occupancy | $26,145 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $410,272 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $12,432 |
Insurance | $10,062 |
All other expenses | $165,198 |
Total functional expenses | $1,347,815 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $153,700 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $23,595 |
Net Land, buildings, and equipment | $10,514 |
Investments—publicly traded securities | $1,881,990 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $2,069,799 |
Accounts payable and accrued expenses | $47,382 |
Grants payable | $0 |
Deferred revenue | $162,187 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $209,569 |
Net assets without donor restrictions | $1,693,275 |
Net assets with donor restrictions | $166,955 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $2,069,799 |
Over the last fiscal year, we have identified 1 grants that American Society Of Cytopathology has recieved totaling $111.
Awarding Organization | Amount |
---|---|
Amazonsmile Foundation Seattle, WA PURPOSE: GENERAL SUPPORT | $111 |
Organization Name | Assets | Revenue |
---|---|---|
Maryland University Of Integrative Health Inc Laurel, MD | $11,498,373 | $12,162,798 |
American Uro-Gynecologic Society Silver Spring, MD | $2,850,090 | $2,686,876 |
Internation Congress Of Oral Implantologists Fairfield, NJ | $13,505,131 | $3,593,207 |
National Board Of Podiatric Medical Examiners Inc Bellefonte, PA | $10,488,955 | $2,370,622 |
American Society Of Cytopathology Wilmington, DE | $2,069,799 | $1,320,558 |
American Academy Of Orofacial Pain Oceanville, NJ | $252,612 | $443,927 |
Gbmc Ophthalmology Educational Foundation Inc Towson, MD | $3,151,690 | $149,466 |
Certification Board For Urologic Nurses And Associates Pitman, NJ | $71,506 | $0 |
Pagl Foundation Monroe, NJ | $33,484 | $0 |